AR016054A1 - Mezcla de ácidos grasos primarios , uso de la mezcla y método para obtener la misma - Google Patents
Mezcla de ácidos grasos primarios , uso de la mezcla y método para obtener la mismaInfo
- Publication number
- AR016054A1 AR016054A1 ARP980101504A ARP980101504A AR016054A1 AR 016054 A1 AR016054 A1 AR 016054A1 AR P980101504 A ARP980101504 A AR P980101504A AR P980101504 A ARP980101504 A AR P980101504A AR 016054 A1 AR016054 A1 AR 016054A1
- Authority
- AR
- Argentina
- Prior art keywords
- mixture
- fatty acids
- primary fatty
- mixing
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Abstract
Una mezcla de ácidos grasos primarios de alto peso molecular, formulaciones farmacéuticas que contienen la mezcla y método para obtener la mezcla, donde seaísla y purifica una mezcla natural de ácidos grasos primarios de alto peso molecular, en elra ngo de 24 a 38 átomos de carbono, para el desarrollo deformulaciones farmacéuticas usadas como drogas hipocolesterolémicas e hipolipemiantes, donde el proceso se basa en una saponificacion en fase homogénea de lacera de cana de azucar consoluciones concentradas de hidroxidos alcalinos y alcalino térreos
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU1997035A CU22723A1 (es) | 1997-04-02 | 1997-04-02 | Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos |
Publications (1)
Publication Number | Publication Date |
---|---|
AR016054A1 true AR016054A1 (es) | 2001-06-20 |
Family
ID=5459247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980101504A AR016054A1 (es) | 1997-04-02 | 1998-04-02 | Mezcla de ácidos grasos primarios , uso de la mezcla y método para obtener la misma |
Country Status (20)
Country | Link |
---|---|
US (1) | US6486205B2 (es) |
EP (1) | EP0969827B1 (es) |
JP (2) | JP4907750B2 (es) |
CN (1) | CN1230158C (es) |
AR (1) | AR016054A1 (es) |
AT (1) | ATE233087T1 (es) |
AU (1) | AU732045B2 (es) |
BR (1) | BR9808470A (es) |
CA (1) | CA2285242C (es) |
CO (1) | CO4940484A1 (es) |
CU (1) | CU22723A1 (es) |
DE (1) | DE69811643T2 (es) |
DK (1) | DK0969827T3 (es) |
ES (1) | ES2192769T3 (es) |
HK (1) | HK1029054A1 (es) |
MY (1) | MY120318A (es) |
PT (1) | PT969827E (es) |
RU (1) | RU2217130C2 (es) |
WO (1) | WO1998043631A1 (es) |
ZA (1) | ZA982744B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4666705B2 (ja) * | 1999-12-07 | 2011-04-06 | 三井製糖株式会社 | 消化管潰瘍予防剤または改善剤 |
US20030203854A1 (en) * | 2002-04-23 | 2003-10-30 | Ivo Pischel | Composition for effecting serum cholesterol levels |
AU2003240189A1 (en) * | 2002-06-17 | 2003-12-31 | Medestea Research And Production S.R.L. | Long chain unsaturated oxygenated compounds and their use in the therapeutical, cosmetic and nutraceutical field |
US20050074443A1 (en) * | 2003-10-03 | 2005-04-07 | Treadwell Benjamin V. | Methods of attenuating autoimmune disease and compositions useful therefor |
US20060013842A1 (en) * | 2004-07-15 | 2006-01-19 | Matkin John R | Natural mixture of long-chain fatty alcohols and long-chain fatty acids, its obtension from animal and vegetable waxes and its nutraceutical uses |
US7542034B2 (en) * | 2004-09-23 | 2009-06-02 | Conversion Works, Inc. | System and method for processing video images |
KR100723950B1 (ko) * | 2005-01-04 | 2007-05-31 | 주식회사 하이폭시 | 벼과 식물 추출물을 포함하는 허혈성 질환 및 퇴행성뇌질환의 예방 및 치료를 위한 조성물 |
KR100685681B1 (ko) * | 2005-07-26 | 2007-02-26 | 전북대학교산학협력단 | 수수에서 폴리코사놀 또는 옥타코사놀 함량이 높은긴사슬지방을 제조하는 방법 |
KR20070088784A (ko) * | 2005-10-12 | 2007-08-29 | 시코르, 인크. | 도세탁셀의 결정형 및 이의 제조 방법 |
US20070295326A1 (en) * | 2006-06-07 | 2007-12-27 | Rafael Almagro | Method for obtaining long chain aliphatic alcohols and fatty acids from sugar cane mud and related wax esters |
US20080207748A1 (en) * | 2007-02-22 | 2008-08-28 | Innovation Labs, Inc. | Vitamin c preparation |
DE102010052789A1 (de) * | 2010-11-27 | 2012-05-31 | Wachs-Chemie Elsteraue E.K. | Herstellung und Reinigung von PC-Wachs und deren technische Anwendungen |
KR102429853B1 (ko) * | 2017-11-30 | 2022-08-05 | (주)아모레퍼시픽 | 천연 왁스를 이용한 지방산 조성물 제조방법 및 그에 따라 제조된 지방산 조성물 |
IT201900007329A1 (it) * | 2019-05-27 | 2020-11-27 | Alesco Srl | Composizioni comprendenti acidi grassi cetilati per uso nel trattamento della mucosa gastrica, diabete e alti livelli di glicemia |
CU24638B1 (es) * | 2020-02-03 | 2023-01-16 | Centro Nac De Investigaciones Cientificas | Suspensión oral con efecto antiulceroso y quimioprotector sobre el cáncer de colon |
CU20210060A7 (es) * | 2021-07-13 | 2023-02-13 | Centro Nac De Investigaciones Cientificas | Mezcla de compuestos con altos pesos moleculares, obtenida a partir de la cera de caña de azúcar (saccharum officinarum l.) |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5160207A (en) * | 1974-11-22 | 1976-05-26 | Dai Ichi Kogyo Seiyaku Co Ltd | Shibosanto kokyuarukooruno bunriho |
JPH0610146B2 (ja) * | 1985-10-12 | 1994-02-09 | 住友精化株式会社 | 直鎖第1級脂肪族高級アルコ−ルの抽出法 |
JPH04502167A (ja) * | 1989-10-13 | 1992-04-16 | メダフオール | 長鎖脂肪アルコール誘導体、特に細胞栄養分子及び細胞保護分子としてのその使用、並びに、該誘導体を含有する医薬組成物 |
CU22225A1 (es) * | 1990-11-30 | 1995-01-31 | Cent Nac Investig Scient | Composicion farmacautica que contiene mezcla de alcoholes alifaticos primarios superiores para el tratamiento de hipercolesterolemia y la hiperlipoproteinemia tipo ii asi como estimulante de la conducta sexual en animales y humanos |
CU22229A1 (es) * | 1992-09-29 | 1996-01-31 | Dalmer Lab Sa | Policosanol, una mezcla de alcoholes alifaticos primarios superiores para hipergregabilidad plaquetaria, los accidentes isquemicos, trombosis e incluso efectividad contra ulceras gastricas quimicamente inducidas y su proceso de obtencion de la caña de azucar. el tratamiento de complicaciones ateroscleroticas tales como la |
JPH06122892A (ja) * | 1992-10-09 | 1994-05-06 | Nippon Petrochem Co Ltd | 粗ワックスの製造方法 |
CU22412A1 (es) * | 1993-11-09 | 1996-01-31 | Dalmer Lab Sa | Una mezcla natural compuesta por alcoholes alifaticos primarios superiores obtenidos de la cera de abejas para el tratamiento de las ulceras gastricas y duodenales que presenta tambien actividad antiinflamatoria |
US5554379A (en) * | 1994-06-20 | 1996-09-10 | Kv Pharmaceutical Company | Long acting GI and esophageal protectant |
JP2804445B2 (ja) * | 1994-11-30 | 1998-09-24 | ラボラトリオス ダルマー ソシエダッド アノニマ | 胃潰瘍および十二指腸潰瘍の処置剤および抗炎症剤 |
US6039950A (en) * | 1995-04-14 | 2000-03-21 | University Of Southern California | Pharmaceutical grade saw palmetto |
US6080787A (en) * | 1997-02-21 | 2000-06-27 | Abbott Laboratories | Methods for reducing the incidence of necrotizing enterocolitis |
AUPO605097A0 (en) * | 1997-04-07 | 1997-05-01 | James Cook University Of North Queensland | Food grade wax and process for preparing same |
-
1997
- 1997-04-02 CU CU1997035A patent/CU22723A1/es unknown
-
1998
- 1998-04-01 CN CNB988055880A patent/CN1230158C/zh not_active Expired - Lifetime
- 1998-04-01 WO PCT/IB1998/000870 patent/WO1998043631A1/en active IP Right Grant
- 1998-04-01 BR BR9808470-4A patent/BR9808470A/pt not_active Application Discontinuation
- 1998-04-01 AT AT98920719T patent/ATE233087T1/de not_active IP Right Cessation
- 1998-04-01 JP JP54135598A patent/JP4907750B2/ja not_active Expired - Lifetime
- 1998-04-01 US US09/402,292 patent/US6486205B2/en not_active Expired - Fee Related
- 1998-04-01 CO CO98018329A patent/CO4940484A1/es unknown
- 1998-04-01 EP EP98920719A patent/EP0969827B1/en not_active Expired - Lifetime
- 1998-04-01 ZA ZA982744A patent/ZA982744B/xx unknown
- 1998-04-01 DE DE69811643T patent/DE69811643T2/de not_active Expired - Lifetime
- 1998-04-01 MY MYPI98001431A patent/MY120318A/en unknown
- 1998-04-01 RU RU99123062/14A patent/RU2217130C2/ru active
- 1998-04-01 DK DK98920719T patent/DK0969827T3/da active
- 1998-04-01 ES ES98920719T patent/ES2192769T3/es not_active Expired - Lifetime
- 1998-04-01 CA CA002285242A patent/CA2285242C/en not_active Expired - Lifetime
- 1998-04-01 AU AU73494/98A patent/AU732045B2/en not_active Expired
- 1998-04-01 PT PT98920719T patent/PT969827E/pt unknown
- 1998-04-02 AR ARP980101504A patent/AR016054A1/es active IP Right Grant
-
2000
- 2000-12-21 HK HK00108344A patent/HK1029054A1/xx not_active IP Right Cessation
-
2011
- 2011-11-16 JP JP2011250436A patent/JP2012067119A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
BR9808470A (pt) | 2000-05-23 |
US20020058705A1 (en) | 2002-05-16 |
EP0969827B1 (en) | 2003-02-26 |
DE69811643D1 (de) | 2003-04-03 |
DK0969827T3 (da) | 2003-06-16 |
ATE233087T1 (de) | 2003-03-15 |
HK1029054A1 (en) | 2001-03-23 |
ZA982744B (en) | 1998-10-08 |
WO1998043631A1 (en) | 1998-10-08 |
CU22723A1 (es) | 2002-02-28 |
RU2217130C2 (ru) | 2003-11-27 |
CA2285242A1 (en) | 1998-10-08 |
JP2012067119A (ja) | 2012-04-05 |
US6486205B2 (en) | 2002-11-26 |
AU7349498A (en) | 1998-10-22 |
AU732045B2 (en) | 2001-04-12 |
EP0969827A1 (en) | 2000-01-12 |
PT969827E (pt) | 2003-07-31 |
CN1258218A (zh) | 2000-06-28 |
CN1230158C (zh) | 2005-12-07 |
JP2001518092A (ja) | 2001-10-09 |
CO4940484A1 (es) | 2000-07-24 |
CA2285242C (en) | 2008-12-16 |
JP4907750B2 (ja) | 2012-04-04 |
MY120318A (en) | 2005-10-31 |
DE69811643T2 (de) | 2003-12-24 |
ES2192769T3 (es) | 2003-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR016054A1 (es) | Mezcla de ácidos grasos primarios , uso de la mezcla y método para obtener la misma | |
PT82186B (pt) | Processo para a preparacao de novos derivados de gama-ciclodextrina e de composicoes farmaceuticas que os contem | |
NZ509418A (en) | Pharmaceutical formulations for aerosols with two or more active substances | |
DE19581804T1 (de) | Pharmazeutische Zusammensetzungen | |
EA200100002A1 (ru) | Бензотиепины, обладающие активностью ингибиторов перемещения желчных кислот в подвздошной кишке и поглощения таурхолата | |
GT199900146A (es) | Derivados de 4,4-biarilpiperidina. | |
CN1097735A (zh) | 脂肪酸衍生物和含有脂肪酸衍生物的药物组合物 | |
KR870006896A (ko) | 서방성 약제학적 제제의 제조방법 | |
PT90764A (pt) | Processo para a preparacaode um produto farmaceutico compreendendo um estrogenio e um anti-estrigenio e de composicoes farmaceuticas que os contem | |
ES2128735T3 (es) | Composiciones farmaceuticas que comprenden un antagonista de opiaceos y de sales de calcio y su uso para el tratamiento de patologias en las que intervienen las endorfinas. | |
AR012294A1 (es) | Derivados de sulfonamida, un procedimiento para su preparacion, composiciones farmaceuticas que los contienen, uso de dichos derivados para lapreparacion de un medicamento. | |
DE69809074D1 (de) | Herstellung von arzneimitteln | |
AR020999A1 (es) | Composiciones y proceso para la elaboracion de isotretinoina | |
KR960700061A (ko) | 니코틴 의존상태 치료를 위한 약리학적 제형 (pharmaceutical composition for treating nicotine dependence) | |
AR031117A1 (es) | Uso de inhibidores de lipasa y secuestrantes de acido biliar para la preparacion de un medicamento, dicho inhibidor de lipasa y secuestrante de acido biliar y combinacion farmaceutica | |
ES2052166T3 (es) | Derivados de 24-homo-vitamina-d, procedimiento para su preparacion, preparados farmaceuticos que contienen estos derivados asi como su utilizacion como medicamentos. | |
BR0208468A (pt) | Camsilato de amlodipina e processo para sua preparação | |
BR0112821A (pt) | Formulação aperfeiçoada de aditivo para combustìvel e processo de uso | |
BR9304431A (pt) | Medicamento processo para sua preparaçao e aplicaçao de uma mistura | |
BR0107899A (pt) | Processo para produzir uma preparação de ingrediente ativo compreendendo ibuprofeno, preparação de ingrediente ativo, uso da mesma, preparação farmacêutica, uso da mesma, processo para produzir formas de dosagem sólidas, e, forma de dosagem sólida | |
ECSP941120A (es) | Derivados de 1,5 benzodiazepina | |
AR003107A1 (es) | Derivados de vitamina d para uso dermatologico, composiciones farmaceuticas que los contienen y procedimiento para la preparacion de dichos derivados. | |
MX170961B (es) | Procedimiento para la preparacion de esteres epoxicos y substancias intermediarias preparadas mediante el mismo | |
CA2417597A1 (en) | Process for the production of phospholipids | |
MX9307203A (es) | COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |